Cellular therapies have recently revolutionized the treatment of numerous blood cancers. However, the current limitations in their manufacturing process have resulted in exorbitant prices, restricting their widespread accessibility. Currently, only 2% of patients have access to these therapies. By bringing our proprietary deep tech technology from research to the market, our goal is to revolutionize the manufacturing of cellular therapies, making these groundbreaking treatments… Show more Cellular therapies have recently revolutionized the treatment of numerous blood cancers. However, the current limitations in their manufacturing process have resulted in exorbitant prices, restricting their widespread accessibility. Currently, only 2% of patients have access to these therapies. By bringing our proprietary deep tech technology from research to the market, our goal is to revolutionize the manufacturing of cellular therapies, making these groundbreaking treatments accessible to a wider population. Show less

Project at the interface between physics/chemistry/biology and clinics aims at dissecting the response of the tumor microenvironment to therapeutic approaches combining nanoparticles-mediated hyperthermia and chemotherapy or immunotherapy.

"Towards a universal flow sensor for Microfluidics"These CIFRE in collaboration between Fluigent company and the Curie Institute (Physico-Chimie Curie Lab) supervised by Jean-Louis Viovy and Stéphanie Descroix. The aim of this project was to develop a disposable flow sensor for microfluidics working independently of the liquid properties .

Laboratoire de génie des procédés plasmas et traitement de surface:Plasma DBD activated ceria-zirconia-promoted Ni-catalysts for plasma catalytic CO2 hydrogenation at low temperaturePublished article: Benrabbah, R., Cavaniol, C., Liu, H., Ognier, S., Cavadias, S., Gálvez, M.E., DaCosta, P., 2017. Plasma DBD activated ceria-zirconia-promoted Ni-catalysts forplasma catalytic CO2 hydrogenation at low temperature. CatalysisCommunications 89, 73–76

Laboratoire de Pneumologie et Physiologie Respiratoire: Experimental and numerical study of lung complianceon forced expiry Published Article:Comparison between measured and simulated forced expiration flow volumeloops. Revue des Maladies Respiratoires 31, 679-680